Trials / Unknown
UnknownNCT03210389
A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.
A Prospective, Single-arm, and Open Clinical Trial of Chemotherapy With Lobaplatin and 5-FU on Efficacy and Safety in Recurrent Local or Distant Advanced NPC.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of chemotherapy with Lobaplatin and 5-FU, in Recurrent Local or Distant Advanced Nasopharyngeal Carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lobaplatin | Patients enrolled will receive lobaplatin 30mg/m2 d1+ 5-FU 0.5g/m2/d d2-5 in every 21days. 4-6 cycles of chemotherapy are recommended. |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2019-12-01
- Completion
- 2021-12-01
- First posted
- 2017-07-06
- Last updated
- 2017-07-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03210389. Inclusion in this directory is not an endorsement.